Actavis completes its acquisition of Higia AD in Bulgaria
The combination of Actavis' strong portfolio and manufacturing capabilities with Higia's strategically important foothold in the distribution of pharmaceuticals in Bulgaria, is expected to generate significant opportunities to drive Actavis' revenue growth in this important market. Currently, Bulgaria is the Group's second largest market, with some EUR46 million in sales for first nine months in 2005 (12% of Group product sales). Higia's distribution network covers over 2000 pharmacies and has a significant share of pharmacy and hospital sales in the Bulgarian market.
The purchase price was not disclosed and the transaction will be financed through a long-term credit facility.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.